Funding, M&A and exec moves matched to your market, from $49/mo billed annually, or $79/mo quarterly.See plans and pricing.See plans →
Medicinova Terminates $30 Million Equity Purchase Agreement with Yorkville
PUBLIC · MNOVAug 31, 2026•4 days ago
Amount Raised
$30 Million
Round Type
Venture - Series Unknown
San DiegoBiotechnologyHealth CareTherapeuticsBiopharma
Investors
YorkvilleYa Ii Pn, Ltd.
Description
On August 31, 2026, Medicinova, Inc. notified Yorkville of its decision to terminate the Standby Equity Purchase Agreement. The termination will take effect on September 8, 2026. Previously, the agreement allowed Medicinova to issue and sell shares worth up to $30 million
Company Information
Company
MediciNova
Location
San Diego, California, United States
About
MediciNova, Inc. is a biopharmaceutical company focused on the development of novel anti-inflammatory treatments for neurodegenerative diseases, malignant brain cancers, and metabolic diseases.
Don't miss MediciNova's next move
Get an email the moment MediciNova raises, hires an exec, or expands, usually minutes after it happens.